Oliver TG, Patel J, Akerley W. Squamous non-small cell lung cancer as a distinct clinical entity. Am J Clin Oncol. 2015;38(2):220-26.Oliver TG, Patel J, Akerley W. Squamous non-small cell lung cancer as a distinct clinical entity. J Clin Oncol 2015;38:220-6....
Immunotherapeutic Approaches to the Treatment of Squamous Non-Small Cell Lung CancerR. Herbst
Despite advances in the treatment of patients with nonsquamous non–small-cell lung cancer (NSCLC), lung cancer remains a leading cause of death globally. Studies have demonstrated that survival varies according to histological subtype, and, in many cases, patients with squamous NSCLC have a poorer...
文献推荐:大型III期验证性临床研究 | First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial ...
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as Treatment for Advanced Squamous Non–Small-Cell Lung Cancer View LargeDownload Figure 1. Study Profile View LargeDownload Patients who discontinued treatment for any reason were included in follow-up. AUC indicates area under the concentration; ...
Lung Cancer: Targets and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article Review Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer This article was published in the following Dove Press journal: Lung Cancer:Targets ...
H sia TC, Tu CY, Chen HJ.The impact of rescue or maintenance therapy with EGFR TKIs for Stage Ⅲ b-Ⅳ non- squamous non-smal-l cell lung cancer patients requiring mechanical ventilation[J].BMC Anesthesiol,2 0 1 4 ,1 4 :5 5 ....
Lung Diseases Department, San Camillo-Forlanini High Specialization Hospitals, Rome, Italy; 2Sperimental Medicine Department, Rome, Italy Abstract: Pemetrexed is a new cytotoxic agent that is a standard of care for the second-line treatment of non-small cell lung cancer (NSCLC) and in combination...
Pemetrexed in Nonsquamous Non–Small-Cell Lung Cancer: The Billion Dollar Subgroup Analysis 来自 NCBI 喜欢 0 阅读量: 10 作者:B Gyawali,V Prasad 摘要: Recently, two clinical trials of novel agents in metastatic ovarian cancer were published: a phase 3 study of nintedanib and a phase 2 study...
First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: a Bayesian network meta-analysis of randomized controlled trials. Cancer Med. 2022;11(10):2043-2055. doi:10.1002/cam4.4589 PubMedGoogle Scholar...